Search

What do systematic reviews say?

4,929 questions · 15,213 findings · 2,394 reviews

Sort:Best matchNewestHighest certainty Download CSV

No studies found 15,213 · 100%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Infant Flow CPAP vs continuous positive airway pressure (CPAP)

Neurodevelopmental outcomes · preterm infants with apnea

The review found no eligible studies for this question.

1 finding from 1 review

Continuous positive airway pressure (CPAP) for apnoea of prematurity 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Continuous positive airway pressure (CPAP) plus best supportive care vs supportive care

Mean apnoea events · preterm infants with apnea

The review found no eligible studies for this question.

1 finding from 1 review

Continuous positive airway pressure (CPAP) for apnoea of prematurity 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Continuous positive airway pressure (CPAP) plus best supportive care vs supportive care

Adverse events · preterm infants with apnea

The review found no eligible studies for this question.

1 finding from 1 review

Continuous positive airway pressure (CPAP) for apnoea of prematurity 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Continuous positive airway pressure (CPAP) plus best supportive care vs supportive care

Neurodevelopmental outcomes · preterm infants with apnea

The review found no eligible studies for this question.

1 finding from 1 review

Continuous positive airway pressure (CPAP) for apnoea of prematurity 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Variable flow vs ventilator CPAP

Neurodevelopmental outcomes · preterm infants with apnea

The review found no eligible studies for this question.

1 finding from 1 review

Continuous positive airway pressure (CPAP) for apnoea of prematurity 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Variable flow vs bubble CPAP

Failed CPAP · preterm infants with apnea

The review found no eligible studies for this question.

1 finding from 1 review

Continuous positive airway pressure (CPAP) for apnoea of prematurity 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Variable flow vs bubble CPAP

Mean apnoea events · preterm infants with apnea

The review found no eligible studies for this question.

1 finding from 1 review

Continuous positive airway pressure (CPAP) for apnoea of prematurity 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Pravastatin 10 to 80 mg/day (6 to 156 weeks) · participants with normal or abnormal lipid profiles

The review found no eligible studies for this question.

1 finding from 1 review

Pravastatin for lowering lipids 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Gait training protocol focused on impairment level vs gait training protocol focused on task level

Quality of life · people with transtibial amputation due to peripheral arterial disease or diabetes

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for motor rehabilitation in people with transtibial amputation due to peripheral arterial disease or… 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Gait training protocol focused on impairment level vs gait training protocol focused on task level

Phantom limb pain frequency · people with transtibial amputation due to peripheral arterial disease or diabetes

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for motor rehabilitation in people with transtibial amputation due to peripheral arterial disease or… 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Motor imaging vs usual care

Adverse events · people with transtibial amputation due to peripheral arterial disease or diabetes

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for motor rehabilitation in people with transtibial amputation due to peripheral arterial disease or… 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Motor imaging vs usual care

Mortality – all causes · people with transtibial amputation due to peripheral arterial disease or diabetes

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for motor rehabilitation in people with transtibial amputation due to peripheral arterial disease or… 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Motor imaging vs usual care

Quality of life · people with transtibial amputation due to peripheral arterial disease or diabetes

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for motor rehabilitation in people with transtibial amputation due to peripheral arterial disease or… 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Motor imaging vs usual care

Phantom limb pain frequency · people with transtibial amputation due to peripheral arterial disease or diabetes

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for motor rehabilitation in people with transtibial amputation due to peripheral arterial disease or… 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Gait training protocol focused on impairment level vs gait training protocol focused on task level

Mortality ‐ all cause · people with transtibial amputation due to peripheral arterial disease or diabetes

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for motor rehabilitation in people with transtibial amputation due to peripheral arterial disease or… 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Intralesional classical immunosuppresants (betamethasone or triamcinolone) vs placebo

Health‐related quality of life ‐ not reported · adults with alopecia areata

The review found no eligible studies for this question.

1 finding from 1 review

Treatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Intralesional classical immunosuppresants (betamethasone or triamcinolone) vs placebo

Long‐term hair regrowth ≥ 75% (greater than 26 weeks of · adults with alopecia areata

The review found no eligible studies for this question.

1 finding from 1 review

Treatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Subcutaneous biologics (dupilumab) vs placebo

Health‐related quality of life ‐ not reported · adults with alopecia areata

The review found no eligible studies for this question.

1 finding from 1 review

Treatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Subcutaneous biologics (dupilumab) vs placebo

Long‐term hair regrowth ≥ 75% (greater than 26 weeks of · adults with alopecia areata

The review found no eligible studies for this question.

1 finding from 1 review

Treatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Oral small molecule inhibitors (apremilast or baricitinib) vs placebo

Health‐related quality of life ‐ not reported · adults with alopecia areata

The review found no eligible studies for this question.

1 finding from 1 review

Treatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found